JP6020396B2 - アゾール誘導体を含有する医薬 - Google Patents

アゾール誘導体を含有する医薬 Download PDF

Info

Publication number
JP6020396B2
JP6020396B2 JP2013186829A JP2013186829A JP6020396B2 JP 6020396 B2 JP6020396 B2 JP 6020396B2 JP 2013186829 A JP2013186829 A JP 2013186829A JP 2013186829 A JP2013186829 A JP 2013186829A JP 6020396 B2 JP6020396 B2 JP 6020396B2
Authority
JP
Japan
Prior art keywords
compound
group
methyl
pyrrolidin
difluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013186829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014074018A (ja
JP2014074018A5 (enExample
Inventor
直哉 小野
直哉 小野
翔一 黒田
翔一 黒田
白崎　仁久
仁久 白崎
哲男 高山
哲男 高山
喜功 関口
喜功 関口
文仁 牛山
文仁 牛山
裕輔 岡
裕輔 岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2013186829A priority Critical patent/JP6020396B2/ja
Publication of JP2014074018A publication Critical patent/JP2014074018A/ja
Publication of JP2014074018A5 publication Critical patent/JP2014074018A5/ja
Application granted granted Critical
Publication of JP6020396B2 publication Critical patent/JP6020396B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013186829A 2012-09-12 2013-09-10 アゾール誘導体を含有する医薬 Expired - Fee Related JP6020396B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013186829A JP6020396B2 (ja) 2012-09-12 2013-09-10 アゾール誘導体を含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012200100 2012-09-12
JP2012200100 2012-09-12
JP2013186829A JP6020396B2 (ja) 2012-09-12 2013-09-10 アゾール誘導体を含有する医薬

Publications (3)

Publication Number Publication Date
JP2014074018A JP2014074018A (ja) 2014-04-24
JP2014074018A5 JP2014074018A5 (enExample) 2014-12-25
JP6020396B2 true JP6020396B2 (ja) 2016-11-02

Family

ID=50748467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013186829A Expired - Fee Related JP6020396B2 (ja) 2012-09-12 2013-09-10 アゾール誘導体を含有する医薬

Country Status (1)

Country Link
JP (1) JP6020396B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2976327A1 (en) * 2015-02-25 2016-09-01 Taisho Pharmaceutical Co., Ltd. Hair growth composition for cutaneous application
CN113248501B (zh) * 2021-06-17 2021-10-08 南京韦尔优众医药有限公司 Cly系列化合物及其制备方法和制备药物的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945441A (en) * 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
GB9804426D0 (en) * 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
JP4240978B2 (ja) * 2002-09-30 2009-03-18 大正製薬株式会社 アリールオキシメチルオキサジアゾール誘導体
JPWO2008075735A1 (ja) * 2006-12-20 2010-04-15 大正製薬株式会社 脱毛症の予防又は治療剤
TWI534142B (zh) * 2011-03-15 2016-05-21 大正製藥股份有限公司 Azole derivatives

Also Published As

Publication number Publication date
JP2014074018A (ja) 2014-04-24

Similar Documents

Publication Publication Date Title
CN102300461B (zh) Hcv ns5a的抑制剂
EP2714681B1 (en) Substituted sulfonamides useful as antiapoptotic bcl inhibitors
EP2264017A1 (en) Heterocyclic derivative and use thereof
EP2389377B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
EP4389738A1 (en) Sos1 inhibitor and use thereof
EP2017263A1 (en) Heteroarylamide lower carboxylic acid derivative
BR112015020472B1 (pt) composto de fosforamidato de nucleosídeo, composição farmacêutica e uso do mesmo
KR20090020712A (ko) 신규한 피리딘 유도체
JP5828339B2 (ja) アゾール誘導体
JP6020396B2 (ja) アゾール誘導体を含有する医薬
EP4562015A2 (en) Cdk2 inhibitors and methods of using the same
HK1189580B (en) Azole derivative
NZ615210B2 (en) Azole derivative
CN104788412B (zh) 芳香多环羧酸衍生物
KR20080015800A (ko) 인자 Ｘａ 억제제로서 헤테로아릴-카복실산(설파모일알킬)아미드-유도체
HK1166445A (en) Inhibitors of hcv ns5a

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151013

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160510

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160809

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160906

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160919

R150 Certificate of patent or registration of utility model

Ref document number: 6020396

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees